Preferred stock, shares issued (in Shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (in Shares) Preferred Stock, Shares Outstanding Class of Stock [Axis] Statement [Line Items] Statement of Financial Position [Abstract] Statement [Table] Loss per common share – basic (in Dollars per share) Earnings Per Share, Basic Loss per common share – diluted (in Dollars per share) Earnings Per Share, Diluted General and administrative General and Administrative Expense Income Statement [Abstract] Options exercised (in Shares) Option/SARs Exercised The number of options/SARs exercised. Options exercised Options/SARs Exercised The amount of options/SARs exercised. Common Stock Common Stock [Member] Common Stock [Member] Other (expenses) income: Nonoperating Income (Expense) [Abstract] Accumulated Deficit Retained Earnings [Member] Loss from operations Operating Income (Loss) Interest/investment income, net Investment Income, Interest Operating expenses: Operating Expenses [Abstract] Exercise of pre-funded warrants for common stock The amount of exercise of pre-funded warrants for common stock. Exercise of pre-funded warrants for common stock (in shares) The number of exercise of pre-funded warrants for common stock (in shares) Stock issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs ATM fees Adjustments to Additional Paid in Capital ATM Fees Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with Atm fees. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. Balance Balance Total stockholders’ equity Equity, Attributable to Parent Cashless exercise of pre-funded warrants for common stock (in Shares) Cashless Exercise Of Prefunded Warrant For Common Stock Number of cashless exercise of pre-funded warrants for common stock. Proceeds from issuance of common stock, net Stock Issued During Period, Value, New Issues Realized (loss) gain on short-term investments Realized loss/(gain) on short-term investments Realized Investment Gains (Losses) Research and development Research and Development Expense Total operating expenses Operating Expenses Issuance of Restricted Common Stock Stock Issued During Period, Value, Restricted Stock Award, Gross Balance (in Shares) Balance (in Shares) Shares, Outstanding Weighted average number of common shares outstanding – basic (in Shares) Weighted Average Number of Shares Outstanding, Basic Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Net loss Net loss Net loss (in Dollars) Weighted average number of common shares outstanding – diluted (in Shares) Weighted Average Number of Shares Outstanding, Diluted Stock based compensation APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Issuance of Restricted Common Stock (in Shares) Restricted common stock Stock Issued During Period, Shares, Restricted Stock Award, Gross Proceeds from issuance of common stock, net (in Shares) Shares issued (in Shares) Shares issued Stock Issued During Period, Shares, New Issues Cashless exercise of pre-funded warrants for common stock Cashless Exercise Of Prefunded Warrants For Common Stock Cashless exercise of pre-funded warrants for common stock. Unrealized (loss) gain on short-term investments Unrealized loss/(gain) on short-term investments Unrealized Gain (Loss) on Investments Total other income Nonoperating Income (Expense) Additional Paid-in Capital Additional Paid-in Capital [Member] Equity Component [Domain] BUSINESS Nature of Operations [Text Block] Proceeds from warrants exercised for common stock Proceeds from Warrant Exercises Payment of fees for issuance of common stock Payments for Repurchase of Common Stock Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Stock Appreciation Rights [Abstract] STOCKHOLDERS’ EQUITY Equity [Text Block] Commitments and Contingencies [Abstract] OTHER POSTRETIREMENT BENEFIT PLAN Retirement Benefits [Text Block] Business [Abstract] Segment Reporting [Abstract] Net increase/(decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Schedule of Prepaid Expenses Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of Anti-Dilutive Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Prepaid Expenses [Abstract] Accrued Expenses [Abstract] Net Loss per Common Share Earnings Per Share, Policy [Policy Text Block] Pre-Funded Warrants Pre Funded Warrants Policy Text Block Disclosure of accounting policy pre-funded warrants. Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Schedule of Weighted Average fair Value of Options Granted Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Stockholders’ Equity [Abstract] Schedule of Components of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Recent Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Summary of Significant Accounting Policies [Abstract] Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Subsequent Events [Abstract] Aggregate offering price (in Dollars) Sale of Stock, Consideration Received on Transaction Long-Lived Asset, Class [Axis] Schedule of Changes in Options [Abstract] Maximum [Member] Maximum [Member] Negative operating cash flow (in Dollars) Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Corporate securities Corporate Security Amount of corporate security. Number of Shares, Warrants Exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Share based compensation arrangements by share based payment number of shares expired. Weighted Average Exercise Price Per Share, Warrants Exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value Number of weighted average exercise price per share, exercised. Number of Shares, Warrants Vested Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Warrants Vested Share based compensation arrangement by share based payment award equity instruments other than options warrants vested. Weighted Average Exercise Price Per Share, Warrants Vested Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Nonvested Weighted Average Vested Share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average vested. Summary of Significant Accounting Policies (Details) [Table] Cash and cash equivalents Cash and Cash Equivalent Operating lease term Lessee, Operating Lease, Remaining Lease Term Mutual fund securities Mutual Fund Security Amount of mutual fund security. Offering shares its common stock (in Shares) Stock Issued During Period, Shares, Issued for Services Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities, Name [Domain] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Derivative Instrument [Axis] Weighted Average Remaining Contractual Term, Outstanding Balance Weighted Average Remaining Contractual Term, Outstanding Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Number of Options, Granted Number of options granted Number of Cash-Settled SARS, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Aggregate Intrinsic Value, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants Value Gross number of share options (or share units) granted intrinsic value during the period. Weighted Average Exercise Price, Cancelled Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Number of Option, Outstanding Balance Number of Option, Outstanding Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Weighted Average Exercise Price, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Aggregate Intrinsic Value, Outstanding Balance Aggregate Intrinsic Value, Outstanding Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Recognized lease expense Operating Lease, Expense Common stock warrants [Member] Warrant [Member] Warrant [Member] Going Concern [Line Items] Stockholders’ Equity [Line Items] Lease term Lessee, Finance Lease, Remaining Lease Term Short-term investments Short-Term Investments Summary of Significant Accounting Policies [Line Items] Pre-funded warrant price Prefunded Warrant Price Pre-funded warrant price. Common stock, par value Common stock, par value (in Dollars per share) Common stock, price per share (in Dollars per share) Common Stock, Par or Stated Value Per Share Class of Warrant or Right [Domain] Purchase Agreement [Member] Purchase Agreement Member Issuance of warrant (in Dollars) Proceeds from Issuance of Warrants Title and Position [Domain] Statistical Measurement [Domain] 2014 Stock Option and Equity Incentive Plan [Member] Two Thousand Fourteen Stock Option And Equity Incentive Plan Member Business (Details) [Table] Class of Stock [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Asset Purchase Agreement [Member] Asset Purchase Agreement Member Total purchase price (in Euro) Total Purchase Price Value Represent the amount of total purchase price. Payment credit to purchase Payment for Purchase, Investment, Operating Activity Number of Options, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Weighted Average Remaining Contractual Term, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Weighted Average Exercise Price, Outstanding Balance Exercise price (in Dollars per share) Weighted Average Exercise Price, Outstanding Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Aggregate Intrinsic Value, Cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Outstanding Intrinsic Value The amount of aggregate intrinsic value cancelled. Number of Options, Cancelled Number of Cash-Settled SARS, Exercised/Cancelled/Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Weighted Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Minimum [Member] Minimum [Member] Statistical Measurement [Axis] Description of CODM Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Reportable segment Number of Reportable Segments Employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Employee contributions percentage Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Segment Reporting [Table] General and Administrative Expenses [Member] General and Administratives Expenses [Member] Uncertain tax positions Unrecognized Tax Benefits, Ending Balance Stockholders' Equity - Schedule of Weighted Average fair Value of Options Granted [Table] Contribution expense (in Dollars) Defined Contribution Plan, Cost Other Postretirement Benefit Plan [Table] Employees contribute matches percentage Defined Contribution Plan, Employer Matching Contribution, Percent of Match Other Postretirement Benefit Plan [Line Items] Milestone payments Milestone Payments Amount of milestone payments. Notice date Number Of Date Of Notice Number of date of notice. License fee Licenses Fee Licenses fee. Lease expiration date Lease Expiration Date Rent amount Payments for Rent Development Development in Process Commercial sale Commercial Sale Of Product Payment Commercial sale of product payment. Other Commitments [Domain] Office Space [Member] Office Space Member Percentage of royalties received Royalties Received Royalties received. Commitments and Contingencies [Line Items] Expected life Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Weighted average remaining service period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Schedule of Components of Stock-Based Compensation Expense [Line Items] General And Administrative [Member] General And Administrative Expenses Member StatementOfIncomeLocationsBalanceDomain [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Derivative Contract [Domain] Options [Member] Option [Member] Stock Options [Member] Equity Option [Member] Schedule of Changes in Options [Line Items] Schedule of Changes in SARs [Line Items] Stock Appreciation Rights [Line Items] Schedule of Weighted Average fair Value of Options Granted [Line Items] Compensation related to cash-settled Total compensation expense Stock-based compensation expense Share-Based Payment Arrangement, Expense Research and Development Prepaid Research And Development Amount of asset related to consideration paid in advance for research and development that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Schedule of Prepaid Expenses [Abstract] Schedule Of Changes In Sars Abstract Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Going Concern [Abstract] Milestone achieved Regulatory Asset Price per share Shares Issued, Price Per Share Pre-Funded Warrant [Member] Pre Funded Warrant Member Class of Warrant or Right [Axis] Exercise price Warrant exercise price (in Dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Warrant to purchase shares of common stock (in Shares) Warrant to purchase shares of common stock Warrant To Purchase Shares Of Common Stock Represents the shares warrant to purchase shares of common stock. Stock Appreciation Rights (SARs) [Member] Long-Term Purchase Commitment, Category of Item Purchased [Domain] Expected dividends Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Total liability (in Dollars) Fair Value, Net Asset (Liability) Discount rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions Expected volatility Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Percentage of royalty payment Royalty Payments Percentage Royalty payments percentage. Unrecognized compensation expense (in Dollars) Unrecognized stock-based compensation expense (in Dollars) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Insurance Prepaid Insurance Legal Prepaid Legal The amount of legal. Number of Cash-Settled SARS, vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Total Prepaid Expense and Other Assets Schedule of Accrued Expenses [Abstract] Aggregate Intrinsic Value, SARs vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Offering price per share Stock price (in Dollars per share) Share Price Going Concern (Details) [Table] Percentage of net sales Net Sales Percentage Percentage of net sales. Percentage of outstanding shares Outstanding Shares Percentage Percentage of outstanding shares. Upfront payment Upfront Payment Amount of upfront payment. Paid amount Payments for Purchase of Other Assets Business [Line Items] Additional milestones Additional Milestones The amount of additional milestones. Risk free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Number of Shares, Outstanding Warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Other Postretirement Benefit Plan [Abstract] Percentage of licensor tiered payments Percentage Of Licensor Tiered Payments Percentage of licensor tiered payments. Upfront fee Upfront Fee Payment The amount of upfront fee. Payment Payments for Other Fees Percentage of outstanding shares Percentage Of Outstanding Shares Percentage of outstanding shares. Stock Appreciation Rights - Schedule of Changes in SARs (Details) [Table] Non-refundable License Fee [Member] Nonrefundable License Fee Member Other Commitments [Axis] Aggregate Intrinsic Value, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Schedule Of Weighted Average Fair Value Of Options Granted Abstract Total Research and Development Expense Total Research and Development Expense Document Information [Line Items] Segment Reporting [Line Items] Segment Reporting [Line Items] Document Fiscal Year Focus Amendment Flag Manufacturing and Drug Storage Expense Manufacturing Costs Clinical Study Expense Preclinical Expenses Amount of pre-clinical expenses. Entity Central Index Key Current assets: Assets, Current [Abstract] Document Information [Table] Document Quarterly Report Schedule Of Operating Expenses Of Our Clinical Stage Drug Development Segment Abstract Segments [Axis] Other Research Expense Research and development compensation expense (in Dollars) Other Research and Development Expense Compensation Expense Employee Benefits and Share-Based Compensation Total current liabilities Liabilities, Current Total liabilities Liabilities Stockholders’ Equity: Equity, Attributable to Parent [Abstract] Common stock, $0.001 par value, 200,000,000 shares authorized, 106,669,846 and 73,333,622 shares issued and outstanding, respectively Common Stock, Value, Issued Accumulated deficit Retained Earnings (Accumulated Deficit) Document Type Entity Filer Category Entity Shell Company Entity Incorporation, State or Country Code Entity Address, Address Line Two Entity Address, State or Province Common stock, shares authorized (in Shares) Common Stock, Shares Authorized Common stock, shares issued (in Shares) Common Stock, Shares, Issued Common stock, shares outstanding (in Shares) Common Stock, Shares, Outstanding Class A Convertible Preferred Stock Convertible Preferred Stock [Member] Preferred stock, par value (in Dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (in Shares) Preferred Stock, Shares Authorized Cash and cash equivalents at end of the period Cash and cash equivalents at beginning of the period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Proceeds from options exercised for common stock Proceeds from Stock Options Exercised Non-cash investing and financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Cashless exercise of warrants for common stock Cashless exercise of warrants for common stock The amount of cashless exercise of warrants for common stock. Stock appreciation rights compensation Stock Appreciation Rights Compensation The amount of stock appreciation rights compensation. Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] STOCK APPRECIATION RIGHTS Share-Based Payment Arrangement [Text Block] PREPAID EXPENSES Other Current Assets [Text Block] GOING CONCERN Substantial Doubt about Going Concern [Text Block] Statement of Cash Flows [Abstract] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Accrued expenses Increase (Decrease) in Accrued Liabilities Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Sale of short-term investments Proceeds from Sale of Short-Term Investments Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Net cash provided/(used in) by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Issuance of restricted common stock Issuance of Restricted Common Stock The amount of issuance of restricted common stock. Other receivable Increase (Decrease) in Other Receivables SUBSEQUENT EVENTS Subsequent Events [Text Block] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] SEGMENT REPORTING Segment Reporting [Text Block] Net cash (used in)/provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation ATM fees Payments of Stock Issuance Costs Change in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Purchase of short-term investments Payments to Acquire Short-Term Investments ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Non-Rule 10b5-1 Arrangement Modified Non Rule10b51 Arrangement Modified Flag The number of modified. Principles of Consolidation Consolidation, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Patents Patents Policy Text Block Disclosure of patents policy text block. Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Research and Development Research and Development Expense, Policy [Policy Text Block] Stock Appreciation Rights Stock Appreciation Rights Policy Text Block Disclosure of accounting policy for stock appreciation rights. Reclassification Reclassification, Comparability Adjustment [Policy Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Short-term Investments Investment, Policy [Policy Text Block] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Events [Line Items] Subsequent Event [Line Items] Exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Changes in Options Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Changes in Outstanding Warrants Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] Schedule of Operating Expenses of Our Clinical Stage Drug Development Segment Segment Reporting [Table Text Block] Rule 10b5-1 Arrangement Modified Rule10b51 Arrangement Modified Flag The number of modified. Weighted Average Remaining Contractual Term, Granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term Duration of weighted average remaining contractual term granted. Development pay Business Development Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Retirement Plan Type [Domain] Other Postretirement Benefits Plan [Member] Other Postretirement Benefits Plan [Member] Retirement Plan Type [Axis] Private investment description Private Investment Description Private investment description. Term of stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Aggregate fair value of options (in Dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Commitments and Contingencies (Details) [Table] Weighted Average Remaining Contractual Term, SARs vested Vested term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term Other Other Prepaid Expense, Current Cashless exercise of warrants Cashless Exercise Of Warrants Cashless exercise of warrants. Weighted Average Exercise Price Per Share, Warrants Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Number of Options, Exercised Common stock exercise shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Aggregate Intrinsic Value, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Weighted Average Exercise Price Per Share, Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisesdDateFairValue The weighted average grant-date fair value of options exercised during the reporting period as calculated by applying the disclosed option pricing methodology. Common stock grants Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Intrinsic value of warrants exercisable (in Dollars) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercisable Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. Stock appreciation rights Stock appreciation rights Weighted Average Exercise Price Per Share, Outstanding Warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Schedule of Changes in Outstanding Warrants [Abstract] Common stock exercise value Stock Issued During Period, Value, Stock Options Exercised Number of Shares, Warrants Granted Number of warrants granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Total Accounts Payable and Accrued Liabilities, Current Accrued vacation Accrued Vacation, Current Lease period Lessee, Operating Lease, Term of Contract Percentage of net sales Percenatge Of Net Sales Percenatge of net sales. Non-refundable license fee Non Refundable License Fee Non refundable license fee. Forecast [Member] Scenario [Domain] Scenario [Axis] Percentage of net sales of sublicensee Percentage of Net Sales Percentage of net sales. Weighted Average Exercise Price, SARs vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Schedule Of Components Of Stock Based Compensation Expense Abstract Statement of Income Locations Balance [Axis] Statement Of Income Locations Balance Axis Research and Development [Member] Research And Development Member Shares issued Number Of Shares Issued Under Agreement Number of shares issued under agreement. License Agreements [Member] License Agreements Member Long-Lived Asset, Class [Domain] Stock Appreciation Rights (Details) [Table] Consultants [Member] Consultants Member Unrealized (loss) gain on short-term investments Unrealized Gain (Loss) On Short Term Investments Amount of unrealized gain (loss) on short term investment. Shares of common stock Stock Issued During Period, Shares, Other Aggregate Intrinsic Value, Granted The amount of aggregate intrinsic value granted. 2021 Equity Incentive Plan [Member] Two Thousand Twenty One Equity Incentive Plan [Member] Board of Directors [Member] Board of Directors Chairman [Member] Title and Position [Axis] Plan Name [Domain] Open Market Sale Agreement [Member] Open Market Sale Agreement Member Stockholders’ Equity (Details) [Table] Stock issued to employees (in Shares) Stock Issued During Period, Shares, Employee Stock Ownership Plan Research and Development Expense [Member] Research and Development Arrangement [Member] Category of Item Purchased [Axis] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Total anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Research and development Accrued Research And Development Current Represent the amount of current accrued research and development. Professional fees Accrued Professional Fees, Current License Agreement [Member] License Agreement Member Restricted Common Stock [Member] Restricted Stock [Member] Plan Name [Axis] Schedule Of Anti Dilutive Securities Abstract Antidilutive Securities [Axis] Schedule of Anti-Dilutive Securities [Line Items] Accrued bonus Accrued Bonuses, Current Other Other Accrued Liabilities, Current Entity Common Stock, Shares Outstanding Security Exchange Name Segments [Domain] Local Phone Number Entity Tax Identification Number Entity Registrant Name Document Fiscal Period Focus Document Period End Date Assets Assets [Abstract] Total liabilities and stockholders’ equity Liabilities and Equity Total current assets Assets, Current Total assets Assets Entity Address, Postal Zip Code Cover [Abstract] Document Transition Report Prepaid expenses Prepaid Expense, Current Current liabilities: Liabilities, Current [Abstract] Accrued expenses Accrued Liabilities, Current Stock appreciation rights Program Rights Obligations, Noncurrent Commitments and Contingencies (See Note 8) Commitments and Contingencies Preferred stock value Preferred Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Other assets Other Assets, Noncurrent Other receivable Accounts and Other Receivables, Net, Current Title of 12(b) Security Trading Symbol Entity Interactive Data Current Entity Address, Address Line One Entity Address, City or Town City Area Code Accounts payable Accounts Payable, Current Current Fiscal Year End Date Entity Current Reporting Status Entity File Number Entity Emerging Growth Company Entity Small Business Other Operating Segment [Member] Chief Executive Office